Z score calculations and GSVA enrichment scores demonstrated the likely role of IFNB1 in SLE pathogenesis and suggested that targeting this IFN in lupus skin and synovium may be more beneficial than blocking IFN in SLE patients with LN. Here, IFNA1 is linked to systemic lupus erythematosus.